Real World Evidence Shows Johnson & Johnson COVID-19 Vaccine Demonstrates Durable Protection Against Breakthrough Infection, Hospitalization, And Intensive Care Unit Admission In The United States

Real World Evidence Shows Johnson & Johnson COVID-19 Vaccine Demonstrates Durable Protection Against Breakthrough Infection, Hospitalization, And Intensive Care Unit Admission In The United States

January 6, 2022

Published by The Street By PR Newswire NEW BRUNSWICK, N.J., Jan. 6, 2022 /PRNewswire/ — Johnson & Johnson (JNJ) – Get Johnson & Johnson Report (the Company) today announced new results from the largest study to date on the durability of COVID-19…

Clarience Technologies Acquires Fleetilla To Strengthen Connectivity Portfolio As Electric And Autonomous Commercial Vehicles Arrive To North America

Clarience Technologies Acquires Fleetilla To Strengthen Connectivity Portfolio As Electric And Autonomous Commercial Vehicles Arrive To North America

January 6, 2022

Published by The Street By PR Newswire SOUTHFIELD, Mich., Jan. 6, 2022 /PRNewswire/ — Clarience Technologies, parent company to Truck-Lite, DAVCO filtration systems and Road Ready advanced telematics, has acquired Fleetilla, an Ann Arbor, Michigan-based telematics provider that serves commercial trucking and…

Hisense Plans to Bring More High Performing and High-quality Display Products to African Market in 2022

January 6, 2022

JOHANNESBURG, South Africa, Jan. 6, 2022 /PRNewswire/ — Hisense, provider of high-performance televisions and appliances, showcased its 8K resolution laser display technology solution and ULED 8K Mini-LED series at the recent Consumer Electronics Show 2022 (“CES 2022”) held in Las Vegas. Following the introduction of the world’s first 8K laser display for homes at the most […]

Zenas BioPharma Appoints Dr. John Orloff to Board of Directors

January 6, 2022

BOSTON and SHANGHAI, China, Jan. 06, 2022 (GLOBE NEWSWIRE) — Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and delivery of immune-based therapies, today announced the appointment of John Orloff, MD to its Board of Directors. Dr. Orloff joins the Zenas Board with over 25 years of experience successfully […]

Harris fait l’acqusition du portefeuille de produits i2 d’IBM

January 6, 2022

OTTAWA, Ontario, et CAMBRIDGE, Royaume-Uni, 05 janv. 2022 (GLOBE NEWSWIRE) — Harris, un fournisseur mondial de logiciels sur le marché vertical, a fait l’acquisition du portefeuille de produits d’analyse du renseignement i2 d’IBM, y compris les plateformes i2 Analyst’s Notebook, i2 Enterprise Insight Analysis (EIA) et i2 iBase. Cette acquisition permet à Harris de continuer […]